Suspended

Randomized Study Comparing Ligation With Propranolol for Primary Prophylaxis of Variceal Bleeding in Candidates for Liver Transplantation

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Data Collection

Who is being recruted

Digestive System Diseases+7

+ Esophageal and Gastric Varices

+ Esophageal Diseases

From 18 to 65 Years
+17 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Prevention Study

Phase 3
Interventional
See protocol details

Summary

Principal SponsorUniversity of Padova
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Whether beta-blockers or banding is the best therapy for primary prophylaxis of variceal bleeding is subject to debate. A randomized comparison between the two treatments was performed in candidates for liver transplantation. Patients with Child B and C cirrhosis with high risk varices and no previous variceal bleeding are randomized to propranolol or variceal bleeding. Primary end point is variceal bleeding

Official TitleRandomized Study Comparing Ligation With Propranolol for Primary Prophylaxis of Variceal Bleeding in Candidates for Liver Transplantation
NCT00337740
Principal SponsorUniversity of Padova
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

120 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Prevention Study

Prevention studies aim to stop a disease from developing. They often involve people at risk and test things like vaccines, lifestyle changes, or preventive medications.


Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 65 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Digestive System DiseasesEsophageal and Gastric VaricesEsophageal DiseasesFibrosisGastrointestinal DiseasesHypertension, PortalLiver CirrhosisLiver DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Criteria

6 inclusion criteria required to participate
liver cirrhosis

child pugh>=B7

studied for transplantation

age between 18 an 65 ys

Show More Criteria

11 exclusion criteria prevent from participating
non cooperation

esophageal varices less than F2 blue

gastric varices

previous variceal surgical or radiological or endoscopical treatment

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Clinica Chirurgica 1^, Policlinico Universitario, Via Giustiniani 2

Padua, ItalyOpen Clinica Chirurgica 1^, Policlinico Universitario, Via Giustiniani 2 in Google Maps
SuspendedOne Study Center